Ehab Farag, MD
For patients undergoing catheter-based neurointerventional procedures, sugammadex (Bridion, Merck) achieves reversal of deep rocuronium neuromuscular blocks significantly faster than neostigmine reverses a moderate neuromuscular block, according to results from a randomized trial.
The study (Anesth Analg 2021;132:1666-1676) also found the time to extubation did not differ significantly between the two reversal agents.
“We know that the neurointerventional procedures require